Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 105   Home Print this page  Email this page Small font size Default font size Increase font size
Year : 1990  |  Volume : 8  |  Issue : 1  |  Page : 11-14

A Comparative Clinical Trial Of Aerosol Budesonide And Oral Prednisolone In Patients Of Bronchial Asthma

Correspondence Address:
K. R Sethuraman

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

The aerosol budesonide was compared with oral prednisolone for its efficacy, tolerability and adrenal suppression. Twenty-eight patients, randomly divided into two groups of 14 patients each, participated in the trial. The study revealed that aerosol budesonide (200 mg twice daily) was significantly more effective than oral prednisolone (0.5 mg/kg body weight) as measured by peak expiratory flow rates (PEFR) and by symptom scores. Further, aerosol budesonide did not produce any hypothalamic – pituitary – adrenal axis suppression while oral prednisolone did.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded102    
    Comments [Add]    

Recommend this journal